How to Participate in a Clinical Trial for Multiple Sclerosis
By Cory Martin – Published on June 23, 2022 – Medically reviewed by Huma Sheikh, MD While there is no…
video: Listen with Suzanne O’Connell, MS Patient Advocate/ founder of Multiple Sclerosis Alliance of Virginia discusses this MS organizations’ role in rural VA
Click to Subscribe for the MS Beacon eNewsletter and MS educational events Visit our MS Learning Channel on YouTube:…
Stuart Schlossman
Ocrelizumab Reduces Thalamic Volume Loss
Ocrelizumab Reduces Thalamic Volume Loss, – Cenobamate Shines in C017 Study, Trial of LRRK2 Inhibitor BIIB122 Commences Using the phase 3…
Stuart Schlossman
Multiple Sclerosis Vlog: DIET and MULTIPLE SCLEROSIS — Wheelchair Weight Loss?
LEARN how to lose weight if you have a slow metabolism due to being in a wheelchair or mobility scooter. …
Stuart Schlossman
Medical Power of Attorney and Multiple Sclerosis
2022 Article written by: Anastasia Climan Medically reviewed by: Evelyn O. Berman, M.D. Being diagnosed with multiple sclerosis (MS) is a life-changing…
Stuart Schlossman
MS Living Well Podcast: Multiple Sclerosis Biomarkers including Blood Tests – an interview led by Barry Singer, MD
April 26, 2022 Photo: Rawpixel Rapid recent advancements have led to blood tests (biomarkers) to track multiple sclerosis disease activity.…
Stuart Schlossman
MS researchers in Buffalo and Boston join forces to understand the most severe, and humbling, cases
April 21, 2022 Scott Scanlon Multiple sclerosis robbed Mary Jo Montani of many abilities late in life. She could barely…
Stuart Schlossman
Smell Test Might Help Predict if MS Treatments Are Working
A measure of the nose’s sensitivity to smell could be used to detect whether treatments for relapsing multiple sclerosis (MS) are…
Stuart Schlossman
Rural Life as a Wheelchair User
This story is for everyone who wonders about how wheelchair users live their best lives outside the urban landscape…
Stuart Schlossman
Results of International Mesenchymal Stem Cell Trial Suggest No Benefits Against Inflammation in Active MS
November 4, 2021 Results have been published from a phase 2 clinical trial conducted at 15 sites in 9 countries,…
Stuart Schlossman
